Luminex Corporation Year-End Earnings Release Scheduled for February 1, 2006
January 17 2006 - 9:30AM
PR Newswire (US)
AUSTIN, Texas, Jan. 17 /PRNewswire-FirstCall/ -- Luminex
Corporation (NASDAQ:LMNX) today announced that it expects to report
year-end 2005 results on Wednesday, February 1, 2006. Results are
scheduled for release after the close of trading. Management will
hold a conference call to discuss the operating highlights and
financial results for the fourth quarter and year ended December
31, 2005, on February 1, 2006, at 5:00 p.m. Eastern time. The
conference call will be webcast live and will be accompanied by a
slide presentation, both of which may be accessed at Luminex
Corporation's website at http://www.luminexcorp.com/. Simply log on
to the web at the address above, go to the Company section and
access the Investor Relations link. Please go to the website at
least 15 minutes prior to the call to register, download and
install any necessary audio/video software. If you are unable to
participate during the live webcast, the call and slides will be
archived for one year on the website using the 'replay' link. The
use of pop-up blocking software may impair your ability to view
webcasts. If you use this software, press and hold the CTRL key
when you click on the Register button. Please contact your IT group
if you are unable to override this feature. Unauthorized recording
or downloading of this event is not permitted. Luminex Corporation
develops, manufactures and markets proprietary biological testing
technologies with applications throughout the life sciences
industry. The Company's xMAP(R) system is an open-architecture,
multi-analyte technology platform that delivers fast, accurate and
cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics research markets.
The Company's xMAP technology is sold worldwide and is in use in
leading research laboratories as well as major pharmaceutical,
diagnostic and biotechnology companies. Further information on
Luminex Corporation or xMAP can be obtained on the Internet at
http://www.luminexcorp.com/. Statements made in this release that
express Luminex's or management's intentions, plans, beliefs,
expectations or predictions of future events are forward-looking
statements. The words "believe," "expect," "intend," "estimate,"
"anticipate," "will," "could," "should" and similar expressions are
intended to further identify such forward-looking statements for
purposes of the Private Securities Litigation Reform Act of 1995.
It is important to note that the Company's actual results or
performance could differ materially from those anticipated or
projected in such forward-looking statements. Factors that could
cause Luminex's actual results or performance to differ materially
include risks and uncertainties relating to, among others, market
demand and acceptance of Luminex's products, the Company's
dependence on strategic partners for development, commercialization
and distribution of products, fluctuations in quarterly results due
to a lengthy and unpredictable sales cycle, Luminex's ability to
scale manufacturing operations, potential shortages of components,
competition, the timing of regulatory approvals and any
modification of the Company's operating plan in response to its
ongoing evaluation of its business, as well as the risks discussed
under the heading "Risk Factors" in Luminex's Annual Report on Form
10-K for the year ended December 31, 2004, as filed with the
Securities and Exchange Commission. The forward-looking statements
contained herein represent the judgment of Luminex as of the date
of this press release, and Luminex expressly disclaims any intent,
obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements to reflect any change
in Luminex's expectations with regard thereto or any change in
events, conditions or circumstances on which any such statements
are based. Contact: Harriss T. Currie Vice President, Finance and
Chief Financial Officer 512-219-8020 First Call Analyst: FCMN
Contact: DATASOURCE: Luminex Corporation CONTACT: Harriss T.
Currie, Vice President, Finance and Chief Financial Officer of
Luminex Corporation, +1-512-219-8020, or Web site:
http://www.luminexcorp.com/
Copyright
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jul 2023 to Jul 2024